BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28405695)

  • 1. [The human microbiome].
    Salzberger B; Lehnert H; Mössner J
    Internist (Berl); 2017 May; 58(5):427-428. PubMed ID: 28405695
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
    Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
    Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
    Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Giving Microbiome: Share the Health.
    Pitashny M
    Isr Med Assoc J; 2016 Oct; 18(10):623-624. PubMed ID: 28471624
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
    Tang G; Yin W; Liu W
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
    Weingarden AR; Vaughn BP
    Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation in children: a brief review.
    Hourigan SK; Oliva-Hemker M
    Pediatr Res; 2016 Jul; 80(1):2-6. PubMed ID: 26982451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of fecal microbiota transplantation suitable for mainstream medicine.
    Khoruts A; Sadowsky MJ; Hamilton MJ
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases.
    Groen AK; Nieuwdorp M
    EMBO Mol Med; 2017 Jan; 9(1):1-3. PubMed ID: 27861129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The microbiome - the unsuspected etiological scope!].
    Füeßl HS
    MMW Fortschr Med; 2015 Apr; 157(8):34. PubMed ID: 26012677
    [No Abstract]   [Full Text] [Related]  

  • 14. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
    Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
    Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome as mediator: Do systemic infections start in the gut?
    Latorre M; Krishnareddy S; Freedberg DE
    World J Gastroenterol; 2015 Oct; 21(37):10487-92. PubMed ID: 26457009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable coexistence of donor and recipient strains after fecal microbiota transplantation.
    Li SS; Zhu A; Benes V; Costea PI; Hercog R; Hildebrand F; Huerta-Cepas J; Nieuwdorp M; Salojärvi J; Voigt AY; Zeller G; Sunagawa S; de Vos WM; Bork P
    Science; 2016 Apr; 352(6285):586-9. PubMed ID: 27126044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.
    Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ
    Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation for treating recurrent Clostridium difficile infection.
    Manag Care; 2013 Jun; 22(6):18-9. PubMed ID: 23841136
    [No Abstract]   [Full Text] [Related]  

  • 20. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.